Peer-Review Record
Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial
Cancers 2020, 12(10), 2790; https://doi.org/10.3390/cancers12102790
by
Manlio Monti 1,*, Paolo Morgagni 2, Oriana Nanni 3
, Massimo Framarini 2, Luca Saragoni 4, Daniele Marrelli 5, Franco Roviello 5, Roberto Petrioli 6, Uberto Fumagalli Romario 7, Lorenza Rimassa 8,9, Silvia Bozzarelli 8, Annibale Donini 10, Luigina Graziosi 10, Verena De Angelis 11, Giovanni De Manzoni 12, Maria Bencivenga 12, Valentina Mengardo 12, Emilio Parma 13, Carlo Milandri 14, Gianni Mura 15, Stefano Rausei 19, Jacopo Viganò 21, Silvia Brugnatelli 22, Flavia Foca 3, add
Show full author list
, Massimo Framarini 2, Luca Saragoni 4, Daniele Marrelli 5, Franco Roviello 5, Roberto Petrioli 6, Uberto Fumagalli Romario 7, Lorenza Rimassa 8,9, Silvia Bozzarelli 8, Annibale Donini 10, Luigina Graziosi 10, Verena De Angelis 11, Giovanni De Manzoni 12, Maria Bencivenga 12, Valentina Mengardo 12, Emilio Parma 13, Carlo Milandri 14, Gianni Mura 15, Stefano Rausei 19, Jacopo Viganò 21, Silvia Brugnatelli 22, Flavia Foca 3, add
Show full author list
Reviewer 1:
Anonymous
Cancers 2020, 12(10), 2790; https://doi.org/10.3390/cancers12102790
Submission received: 9 July 2020
/
Accepted: 24 July 2020
/
Published: 29 September 2020
(This article belongs to the Special Issue Recent Research on Gastrointestinal Carcinoma)
Round 1
Reviewer 1 Report
The reviewer very appreciates evaluating the manuscript again.
Now, the reviewer has confirmed all the authors' replies are properly described.
